- Home
- FEAM vs OKYO Comparison
FEAM vs OKYO Comparison
Compare FEAM & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FEAM | OKYO |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United States | United Kingdom |
| Employees | 35 | N/A |
| Industry | Major Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.4M | 85.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | FEAM | OKYO |
|---|---|---|
| Price | $1.82 | $1.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $6.38 | $6.33 |
| AVG Volume (30 Days) | 344.2K | ★ 361.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.66 | $1.03 |
| 52 Week High | $7.50 | $3.35 |
Technical Indicators
Market Signals| Indicator | FEAM | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 38.30 | 43.91 |
| Support Level | $1.66 | $1.52 |
| Resistance Level | $2.16 | $2.25 |
| Average True Range (ATR) | 0.18 | 0.13 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 31.00 | 60.61 |
Price Performance
Historical ComparisonAbout FEAM 5E Advanced Materials Inc.
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.